Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study
- 30 June 1989
- journal article
- clinical trial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 16, 111-113
- https://doi.org/10.1016/0305-7372(89)90030-3
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2Annals of Surgery, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987